Skip to content

Clinical trials

Observational Lymphoma, Non-Hodgkin trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Observational Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20161
20173
20201
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University3
National Cancer Institute (NCI)2
Ruijin Hospital2
Fudan University1
Peking University First Hospital1
Shanghai Zhongshan Hospital1
Stanford University1
The First Affiliated Hospital of Soochow University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin12
Neoplasms3
Hodgkin Disease2
Lymphoma2
Brain Neoplasms1
Breast Neoplasms1
Leukemia1
Lung Neoplasms1
Lymphoma, Follicular1
Lymphoma, T-Cell, Cutaneous1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.